Clinical Trials Logo

Abscess, Intra-Abdominal clinical trials

View clinical trials related to Abscess, Intra-Abdominal.

Filter by:
  • None
  • Page 1

NCT ID: NCT01110382 Terminated - Infection Clinical Trials

A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections

Start date: December 2010
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the safety and tolerability of doripenem compared with meropenem in children hospitalized with complicated intra-abdominal infections.

NCT ID: NCT01096511 Completed - Clinical trials for Abscess, Intra-Abdominal

Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)

Start date: December 2009
Phase: N/A
Study type: Observational

This study is a local, prospective, open-label, company-sponsored, non interventional, multi-center study. Patients documented must suffer from a cIAI and take at least one dose of Moxifloxacin infusion.The primary objective is to define the types of cIAI infections that require Moxifloxacin i.v. therapy in China.

NCT ID: NCT00629135 Completed - Clinical trials for Abscess, Intra-Abdominal

Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-abdominal Abscesses

Start date: November 15, 2005
Phase: Phase 3
Study type: Interventional

The study is contemplating the antibiotic therapy of intraabdominal abscesses. These abscesses are a serious problem in surgical practice. Associated pathophysiologic effects as for example peritonitis may become life threatening or may lead to extended periods of morbidity with prolonged hospitalization. The objective of the sudy is to evaluate whether the combination of Moxifloxacin and Metronidazole is equivalent to Piperacillin / Tazobactam with regard to clinical outcome and eradication of aerobe and anaerobe pathogens in patients with intra-abdominal abscesses.

NCT ID: NCT00463762 Withdrawn - Appendicitis Clinical Trials

Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.

Start date: May 2007
Phase: Phase 4
Study type: Observational

The primary objective is to collect data on treatment outcomes (clinical and microbiological cure), safety and tolerability of treatment with cefoperazone/sulbactam in patients with serious intra-abdominal and hepatobiliary infections in Slovakia.